Locally advanced and metastatic solid tumor including non-small cell lung carcinoma research hub

A Phase 1b, Open-Label, Dose-Escalation Trial of the Safety of and Antigen-Specific Immune Responses Elicited by VB.10 NEO in Combination With Atezolizumab in Subjects with Locally Advanced and Metastatic Tumors

This study is looking at a new treatment called VB.10 NEO combined with an existing medicine, atezolizumab, for people with advanced cancers. It aims to check if the combination is safe and how it affects the body's immune system to fight cancer.